Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
Clinical trial NCT00252668 · COMPLETED
Trial details
- NCT number
- NCT00252668
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.